COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis

Published:2022-06-14 Issue:3 Volume:3 Page:862-872
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Lim Yeong Jer¹²^ORCID,Khan Umair¹²,Karpha Indrani¹²,Ross Andrew¹,Saif Muhammad¹,Remberger Mats³,Kalakonda Nagesh¹²,Pettitt Andrew R.¹²,Floisand Yngvar¹⁴

Affiliation:

1. Haemato‐oncology Department Clatterbridge Cancer Centre NHS Foundation Trust Liverpool UK

2. Institute of Systems, Molecular and Integrative Biology University of Liverpool Liverpool UK

3. Department of Medical Sciences Uppsala University and KFUE Uppsala University Hospital Uppsala Sweden

4. Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine University of Oslo Oslo Norway

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.465

Reference52 articles.

1. Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London

2. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data

3. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

4. Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy

5. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 and Cancer Care: A Review and Practical Guide to Caring for Cancer Patients in the Era of COVID-19;Current Oncology;2024-09-10

2. Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre–Cellular Therapy SARS-CoV-2 Infection;Clinical Infectious Diseases;2024-03-01

3. Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study;Annals of Hematology;2024-02-21

4. COVID-19 in hematopoietic stem cell transplant recipients during three years of the pandemic: a multicenter study in Brazil;Revista do Instituto de Medicina Tropical de São Paulo;2024

5. COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy;Transplant Infectious Disease;2023-09-28